These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25479241)

  • 1. HIV-1 diversity, transmission dynamics and primary drug resistance in Angola.
    Bártolo I; Zakovic S; Martin F; Palladino C; Carvalho P; Camacho R; Thamm S; Clemente S; Taveira N
    PLoS One; 2014; 9(12):e113626. PubMed ID: 25479241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 genetic diversity and transmitted drug resistance mutations among patients from the North, Central and South regions of Angola.
    Afonso JM; Bello G; Guimarães ML; Sojka M; Morgado MG
    PLoS One; 2012; 7(8):e42996. PubMed ID: 22952625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
    Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
    Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissions.
    Paraskevis D; Kostaki E; Magiorkinis G; Gargalianos P; Xylomenos G; Magiorkinis E; Lazanas M; Chini M; Nikolopoulos G; Skoutelis A; Papastamopoulos V; Antoniadou A; Papadopoulos A; Psichogiou M; Daikos GL; Oikonomopoulou M; Zavitsanou A; Chrysos G; Paparizos V; Kourkounti S; Sambatakou H; Sipsas NV; Lada M; Panagopoulos P; Maltezos E; Drimis S; Hatzakis A
    Infect Genet Evol; 2017 Oct; 54():183-191. PubMed ID: 28688977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic diversity and drug resistance of HIV-1 among infected pregnant women newly diagnosed in Luanda, Angola.
    Sebastião CS; Neto Z; de Jesus CS; Mirandela M; Jandondo D; Couto-Fernandez JC; Tanuri A; Morais J; Brito M
    PLoS One; 2019; 14(11):e0225251. PubMed ID: 31770425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic.
    Bártolo I; Rocha C; Bartolomeu J; Gama A; Marcelino R; Fonseca M; Mendes A; Epalanga M; Silva PC; Taveira N
    Infect Genet Evol; 2009 Jul; 9(4):672-82. PubMed ID: 18562253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phylogenetic investigation of transmission pathways of drug-resistant HIV-1 utilizing pol sequences derived from resistance genotyping.
    Kaye M; Chibo D; Birch C
    J Acquir Immune Defic Syndr; 2008 Sep; 49(1):9-16. PubMed ID: 18667928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare HIV-1 Subtype J Genomes and a New H/U/CRF02_AG Recombinant Genome Suggests an Ancient Origin of HIV-1 in Angola.
    Bártolo I; Calado R; Borrego P; Leitner T; Taveira N
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):822-8. PubMed ID: 27098898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal.
    Palma AC; Araújo F; Duque V; Borges F; Paixão MT; Camacho R;
    Infect Genet Evol; 2007 Jun; 7(3):391-8. PubMed ID: 17360244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
    de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
    J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
    de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 genetic variants circulation in the North of Angola.
    Abecasis A; Paraskevis D; Epalanga M; Fonseca M; Burity F; Bartolomeu J; Carvalho AP; Gomes P; Vandamme AM; Camacho R
    Infect Genet Evol; 2005 Apr; 5(3):231-7. PubMed ID: 15737914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
    Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
    J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14.
    Fabeni L; Alteri C; Di Carlo D; Orchi N; Carioti L; Bertoli A; Gori C; Forbici F; Continenza F; Maffongelli G; Pinnetti C; Vergori A; Mondi A; Ammassari A; Borghi V; Giuliani M; De Carli G; Pittalis S; Grisetti S; Pennica A; Mastroianni CM; Montella F; Cristaudo A; Mussini C; Girardi E; Andreoni M; Antinori A; Ceccherini-Silberstein F; Perno CF; Santoro MM; ;
    J Antimicrob Chemother; 2017 Oct; 72(10):2837-2845. PubMed ID: 29091206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 subtype diversity, transmission networks and transmitted drug resistance amongst acute and early infected MSM populations from Coastal Kenya.
    Hassan AS; Esbjörnsson J; Wahome E; Thiong'o A; Makau GN; Price MA; Sanders EJ
    PLoS One; 2018; 13(12):e0206177. PubMed ID: 30562356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012).
    Ambrosioni J; Sued O; Nicolas D; Parera M; López-Diéguez M; Romero A; Agüero F; Marcos MÁ; Manzardo C; Zamora L; Gómez-Carrillo M; Gatell JM; Pumarola T; Miró JM
    PLoS One; 2015; 10(6):e0125837. PubMed ID: 26039689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and epidemiological characterization of HIV-1 infection networks involving transmitted drug resistance mutations in Northern Greece.
    Skoura L; Metallidis S; Buckton AJ; Mbisa JL; Pilalas D; Papadimitriou E; Papoutsi A; Haidich AB; Chrysanthidis T; Tsachouridou O; Antoniadou ZA; Kollaras P; Nikolaidis P; Malisiovas N
    J Antimicrob Chemother; 2011 Dec; 66(12):2831-7. PubMed ID: 21933785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular transmission network analysis of newly diagnosed HIV-1 infections in Nanjing from 2019 to 2021.
    Shi H; Li X; Wang S; Dong X; Qiao M; Wu S; Wu R; Yuan X; Wang J; Xu Y; Zhu Z
    BMC Infect Dis; 2024 Jun; 24(1):583. PubMed ID: 38867161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Epidemiology and Transmission Dynamics of Recent and Long-Term HIV-1 Infections in Rural Western Kenya.
    Zeh C; Inzaule SC; Ondoa P; Nafisa LG; Kasembeli A; Otieno F; Vandenhoudt H; Amornkul PN; Mills LA; Nkengasong JN
    PLoS One; 2016; 11(2):e0147436. PubMed ID: 26871567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of multiple introductions of HIV-1 subtype C in Angola.
    Afonso JM; Morgado MG; Bello G
    Infect Genet Evol; 2012 Oct; 12(7):1458-65. PubMed ID: 22634597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.